INTERNATIONAL PATENT: QUINCE THERAPEUTICS, INC. FILES APPLICATION FOR "INTRA-ERYTHROCYTE DEXAMETHASONE FOR TREATMENT OF ATAXIA-TELANGIECTASIA"

GENEVA, Aug. 4 -- QUINCE THERAPEUTICS, INC. (611 Gateway Blvd, Suite 273South San Francisco, CA 94080) filed a patent application (PCT/IB2025/050489) for "INTRA-ERYTHROCYTE DEXAMETHASONE FOR TREATMENT OF ATAXIA-TELANGIECTASIA" on Jan 16, 2025. With publication no. WO/2025/158249, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MAMBRINI, Giovanni (Via Antonio Meucci 320091 Bresso)

Abstract: The present disclosure is directed to treating patients with Ataxia-Telangiectasia by administering to the subject at least 5 mg of...